Racial Differences in Outcomes With Dabigatran in Elderly Atrial Fibrillation Patients

被引：0
|
作者：
Kabra, Rajesh
Vaughan-Sarrazin, Mary
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Atrial fibrillation; Dabigatran; Outcomes;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19749
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation
    Shen, Albert Yuh-Jer
    Yao, Janis F.
    Brar, Somjot S.
    Jorgensen, Michael B.
    Chen, Wansu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (04) : 309 - 315
  • [42] Dabigatran versus warfarin in patients with atrial fibrillation.
    Lundelin, K.
    REVISTA CLINICA ESPANOLA, 2010, 210 (03): : 139 - 140
  • [43] Racial Differences in the Prevalence of Atrial Fibrillation in Patients With Dual-Chamber Pacemakers
    Wali, Eisha
    Deshmukh, Amrish
    Bukari, Abdallah
    Ozcan, Cevher
    CIRCULATION, 2017, 136
  • [44] Usage of Dabigatran Versus Warfarin for Patients with Atrial Fibrillation
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2010, 122 (04) : 230 - 231
  • [45] Dabigatran for prophylaxis of thromboembolic events in patients with atrial fibrillation
    Ehrlich, Joachim R.
    Hammwoehner, Matthias
    Goette, Andreas
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2012, 3 : 11 - 21
  • [46] Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
    Weltermann, A.
    Brodmann, M.
    Domanovits, H.
    Eber, B.
    Gottsauner-Wolf, M.
    Halbmayer, W. M.
    Hiesmayr, J. M.
    Kyrle, P. A.
    Laengle, F.
    Roithinger, F. X.
    Watzke, H.
    Windhager, R.
    Wolf, C.
    Zweiker, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (9-10) : 340 - 347
  • [47] USEFULNESS OF DABIGATRAN IN THE PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION
    Tomaru, T.
    Ueshima, M.
    Matsubara, T.
    Matsubara, E.
    Sugiyama, Y.
    CARDIOLOGY, 2013, 125 : 181 - 181
  • [48] Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry
    Golwala, Harsh
    Jackson, Larry R., II
    Simon, DaJuanicia N.
    Piccini, Jonathan P.
    Gersh, Bernard
    Go, Alan S.
    Hylek, Elaine M.
    Kowey, Peter R.
    Mahaffey, Kenneth W.
    Thomas, Laine
    Fonarow, Gregg C.
    Peterson, Eric D.
    Thomas, Kevin L.
    AMERICAN HEART JOURNAL, 2016, 174 : 29 - 36
  • [49] Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Yusuf, Salim
    Eikelboom, John
    Oldgren, Jonas
    Parekh, Amit
    Pogue, Janice
    Reilly, Paul A.
    Themeles, Ellison
    Varrone, Jeanne
    Wang, Susan
    Alings, Marco
    Xavier, Denis
    Zhu, Jun
    Diaz, Rafael
    Lewis, Basil S.
    Darius, Harald
    Diener, Hans-Christoph
    Joyner, Campbell D.
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12): : 1139 - 1151
  • [50] Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis
    Chan, Kevin E.
    Edelman, Elazer R.
    Wenger, Julia B.
    Thadhani, Ravi I.
    Maddux, Franklin W.
    CIRCULATION, 2015, 131 (11) : 972 - 979
12345